Clinical-pathologic correlations in vascular cognitive impairment and dementia

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1862, Issue 5, 2016, Pages 945-951

  Flanagan, Margaret ^a   Larson, Eric B ^b   Latimer, Caitlin S ^a   Cholerton, Brenna ^c   Crane, Paul K ^a   Montine, Kathleen S ^a   White, Lon R ^d,e   Keene, C Dirk ^a   Montine, Thomas J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d PACIFIC HEALTH RESEARCH AND EDUCATION INSTITUTE   (United States)

^e UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOLE; ARTERIOLOSCLEROSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN ARTERY; BRAIN CAPILLARY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN NECROSIS; CADASIL; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; DEMENTIA; HUMAN; LEUKOENCEPHALOPATHY; MORBIDITY; NEUROPATHOLOGY; OCCLUSIVE CEREBROVASCULAR DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; VEIN THROMBOSIS;

EID: 84941710038     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.08.019     Document Type: Article

References (55)

1. Knopman D.S., Petersen R.C., Edland S.D., et al. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology 2004, 62:506-508.
2. Mercy L., Hodges J.R., Dawson K., et al. Incidence of early-onset dementias in cambridgeshire. Neurology 2008, 71:1496-1499.
3. Harvey R.J., Skelton-Robinson M., Rossor M.N. The prevalence and causes of dementia in people under the age of 65 years. J. Neurol. Neurosurg. Psychiatry 2003, 74:1206-1209.
4. Borroni B., Alberici A., Grassi M., et al. Prevalence and demographic features of early-onset neurodegenerative dementia in Brescia county. IAlzheimer Dis. Assoc. Disord. 2011, 25:341-344.
5. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015.
6. Vann Jones S.A., O'Brien J.T. The prevalence and incidence of dementia with lewy bodies: a systematic review of population and clinical studies. Psychol. Med. 2014, 44:673-683.
7. Hebert L.E., Weuve J., Scherr P.A., et al. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 2013, 80:1778-1783.
8. Sonnen J.A., Larson E.B., Crane P.K., et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann. Neurol. 2007, 62:406-413.
9. Montine T.J., Koroshetz W.J., Babcock D., et al. Recommendations of the Alzheimer's disease-related dementias conference. Neurology 2014, 83:851-860.
10. Smith E.E., Schneider J.A., Wardlaw J.M., et al. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012, 11:272-282.
11. van Veluw S.J., Zwanenburg J.J., Rozemuller A.J., et al. The spectrum of MR detectable cortical microinfarcts: a classification study with 7-tesla postmortem MRI and histopathology. J. Cereb. Blood Flow Metab. 2015, 35:676-683.
12. Chahbazian K., Theaudin M., Lehmann P., et al. Reversible pseudo-Creutzfeldt-Jakob syndrome related to cerebral Dural arteriovenous fistula. J. Am. Geriatr. Soc. 2014, 62:2024-2026.
13. Fujii H., Nagano Y., Hosomi N., et al. Dural arteriovenous fistula presenting with progressive dementia and parkinsonism. BMJ Case Rep. 2014, 2014.
14. Labeyrie M.A., Lenck S., Saint-Maurice J.P., et al. Dural arteriovenous fistulas presenting with reversible dementia are associated with a specific venous drainage. Eur. J. Neurol. 2014, 21:545-547.
15. Snyder H.M., Corriveau R.A., Craft S., et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement. 2015, 11:710-717.
16. Joutel A., Corpechot C., Ducros A., et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996, 383:707-710.
17. Joutel A., Andreux F., Gaulis S., et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 2000, 105:597-605.
18. Tikka S., Baumann M., Siitonen M., et al. CADASIL and CARASIL. Brain Pathol. 2014, 24:525-544.
19. De Guio F., Reyes S., Vignaud A., et al. In vivo high-resolution 7 tesla MRI shows early and diffuse cortical alterations in CADASIL. PLoS One 2014, 9.
20. Duering M., Righart R., Csanadi E., et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology 2012, 79:2025-2028.
21. Viswanathan A., Gray F., Bousser M.G., et al. Cortical neuronal apoptosis in CADASIL. Stroke 2006, 37:2690-2695.
22. Jouvent E., Poupon C., Gray F., et al. Intracortical infarcts in small vessel disease: a combined 7-T postmortem MRI and neuropathological case study in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 2011, 42:e27-e30.
23. Hara K., Shiga A., Fukutake T., et al. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N. Engl. J. Med. 2009, 360:1729-1739.
24. Maeda S., Nakayama H., Isaka K., et al. Familial unusual encephalopathy of Binswanger's type without hypertension. Folia Psychiatr. Neurol. Jpn. 1976, 30:165-177.
25. Fukutake T., Hirayama K. Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension. Eur. Neurol. 1995, 35:69-79.
26. Nozaki H., Sekine Y., Fukutake T., et al. Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology 2015.
27. Oide T., Nakayama H., Yanagawa S., et al. Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Neuropathology 2008, 28:132-142.
28. Mandybur T.I. Cerebral amyloid angiopathy: the vascular pathology and complications. J. Neuropathol. Exp. Neurol. 1986, 45:79-90.
29. Linn J., Halpin A., Demaerel P., et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010, 74:1346-1350.
30. Samarasekera N., Smith C., Al-Shahi Salman R. The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 2012, 83:275-281.
31. Obici L., Demarchi A., de Rosa G., et al. A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. Ann. Neurol. 2005, 58:639-644.
32. Natte R., Maat-Schieman M.L., Haan J., et al. Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann. Neurol. 2001, 50:765-772.
33. Ellis R.J., Olichney J.M., Thal L.J., et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience Part XV. Neurology 1996, 46:1592-1596.
34. Yamada M. Cerebral amyloid angiopathy: emerging concepts. J. Stroke 2015, 17:17-30.
35. Castellani R.J., Smith M.A., Perry G., et al. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis. Neurobiol. Aging 2004, 25:599-602.
36. Barelli H., Lebeau A., Vizzavona J., et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 1997, 3:695-707.
37. Miller D.L., Papayannopoulos I.A., Styles J., et al. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 1993, 301:41-52.
38. Thal D.R., Walter J., Saido T.C., et al. Neuropathology and biochemistry of abeta and its aggregates in Alzheimer's disease. Acta Neuropathol. 2015, 129:167-182.
39. Langa K.M., Foster N.L., Larson E.B. Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004, 292:2901-2908.
40. Snowdon D.A., Greiner L.H., Mortimer J.A., et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
41. Esiri M.M., Nagy Z., Smith M.Z., et al. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999, 354:919-920.
42. White L., Petrovitch H., Hardman J., et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia aging study participants. Ann. N. Y. Acad. Sci. 2002, 977:9-23.
43. Troncoso J.C., Zonderman A.B., Resnick S.M., et al. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann. Neurol. 2008, 64:168-176.
44. Strozyk D., Dickson D.W., Lipton R.B., et al. Contribution of vascular pathology to the clinical expression of dementia. Neurobiol. Aging 2010, 31:1710-1720.
45. Brayne C., Richardson K., Matthews F.E., et al. Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75 s cohort (CC75C) study. J. Alzheimers Dis. 2009, 18:645-658.
46. Arvanitakis Z., Leurgans S.E., Barnes L.L., et al. Microinfarct pathology, dementia, and cognitive systems. Stroke 2011, 42:722-727.
47. Nelson P.T., Abner E.L., Schmitt F.A., et al. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol. 2010, 20:66-79.
48. Sonnen J.A., Santa Cruz K., Hemmy L.S., et al. Ecology of the aging human brain. Arch. Neurol. 2011, 68:1049-1056.
49. Vinters H.V., Ellis W.G., Zarow C., et al. Neuropathologic substrates of ischemic vascular dementia. J. Neuropathol. Exp. Neurol. 2000, 59:931-945.
50. Schneider J.A., Boyle P.A., Arvanitakis Z., et al. Subcortical infarcts Alzheimer's disease pathology, and memory function in older persons. Ann. Neurol. 2007, 62:59-66.
51. Kovari E., Gold G., Herrmann F.R., et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 2004, 35:410-414.
52. Kovari E., Gold G., Herrmann F.R., et al. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology 2007, 68:927-931.
53. Nelson P.T., Jicha G.A., Schmitt F.A., et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J. Neuropathol. Exp. Neurol. 2007, 66:1136-1146.
54. Hyman B.T., Phelps C.H., Beach T.G., et al. National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012, 8:1-13.
55. Montine T.J., Phelps C.H., Beach T.G., et al. National institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012, 123:1-11.